Exchange: NASDAQ·Updated 07:35 PM EST

RAPT RAPT Therapeutics Inc

$58.01
$0.04
(0.07%)
Today
Closed $58.02
$0.01
(0.02%)
After Hours
Reported EarningsNov 6
Mkt Cap$1.61B
Vol11.13M

About RAPT

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
49

Neutral Sentiment

How do you feel about RAPT?

Advertisement|Remove ads.